Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis

BACKGROUND: Although adjuvant transcatheter arterial chemoembolization (TACE) has been used to prevent recurrence after surgery in patients with hepatocellular carcinoma (HCC), the survival benefits from adjuvant TACE remain controversial. We sought to systematically evaluate the data on the effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Lei, Li, Chao, Diao, Yong-Kang, Jia, Hang-Dong, Xing, Hao, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Huang, Dong-Sheng, Zhang, Cheng-Wu, Yang, Tian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Diagnosis, Management, and Prognostic Assessment of Liver Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720303/
https://www.ncbi.nlm.nih.gov/pubmed/33329759
http://dx.doi.org/10.1177/1756284820977693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720303/
https://www.ncbi.nlm.nih.gov/pubmed/33329759
http://dx.doi.org/10.1177/1756284820977693

Ejemplares similares